Table 2

Cohort demographic and clinical descriptives of tissue sample donors within the Neuropathology Consortium

	Group; mean (range)^*

Descriptive	Control	MD	Bipolar disorder	Schizophrenia
No. of patient donors	15	15	15	15
Age at death, yr	48.1 (29–68)	46.5 (30–65)	42.3 (25–61)	44.2 (25–62)
Illness duration, yr	—	12.6 (1–42)	20.13 (6–43)	21.3 (5–45)
Age at illness onset, yr	—	33.9 (11–54)	21.5 (7–39)	23.2 (13–42)
Sex, male:female	9:6	9:6	9:6	9:6
PMI, h	23.7 (8–42)	27.5 (7–47)	32.5 (13–62)	33.7 (12–61)
FST, d	338.27 (31–774)	434 (86–931)	620 (224–836)	621.13 (68–938)
pH	6.3 (5.8–6.6)	6.2 (5.6–6.5)	6.2 (5.8–6.5)	6.1 (5.8–6.6)
Hemisphere, right:left	7:8	6:9	8:7	6:9
Antipsychotics^†	0	0	12	14
Fluphenazine equivalents	—	—	26 033 (200–60 000)	56 000 (1 000–2 000)

FST = freezer storage time; MD = major depression; PMI = postmortem interval.
↵* Unless otherwise indicated.
↵† Number of patients with a prescription for antipsychotics at the time of death.